top of page
BW-2020logo.png
Search

Health Stocks Rise on News of Agreement | quick update edition

  • Writer: Jack Borys
    Jack Borys
  • 3 hours ago
  • 1 min read


The Telehealth stock, Hims & Hers (HIMS) soared on Monday, March 9th as Danish drugmaking company Novo Nordisk announced that they will distribute their products on the Hims platform. This ends the long disagreement between the two companies, which sprouted from Novo Nordisk’s claims that Hims was distributing copycat versions of their Wegovy pills, violating patent protections. Novo Nordisk is also on the rise after the news, gaining roughly 2% in mid-morning trading. Hims agrees that they will now offer access to Ozempic and Wegovy at the same price as other telehealth platforms, and will no longer advertise compounded GLP-1 drugs. 



Sources:




 

 

 







 
 
 
bottom of page